Anticipating Financial Results from Revolution Medicines Revolution Medicines, Inc. (Nasdaq: RVMD), an innovative clinical oncology company, has officially announced an upcoming report on its financial results for the first quarter of 2025. This highly anticipated release is scheduled for May 7, 2025, following market close, and will be followed by a detailed discussion...
Continue Reading